Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort

Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort

ABSTRACT Aims/Introduction Diabetic kidney disease (DKD) exacerbates dyslipidemia and increases the incidence of atherosclerotic cardiovascular disease. DKD is a concept that includes typical diabetic nephropathy and an atypical phenotype without proteinuria. We investigated dyslipidemia in differen...

Full description

Bibliographic Details
Main Authors:	Tsutomu Hirano, Noriyuki Satoh, Rieko Kodera, Takeshi Hirashima, Natsuko Suzuki, Ema Aoki, Taito Oshima, Mitsuru Hosoya, Masahiro Fujita, Toshiyuki Hayashi, Yasuki Ito
Format:	Article
Language:	English
Published:	Wiley 2022-04-01
Series:	Journal of Diabetes Investigation
Subjects:	Diabetic kidney disease Low‐density lipoprotein triglycerides Small dense low‐density lipoprotein cholesterol
Online Access:	https://doi.org/10.1111/jdi.13697

Similar Items

The influence of triglycerides on small dense low‐density lipoprotein cholesterol levels is attenuated in low low‐density lipoprotein‐cholesterol range: Implications for the negative results of the PROMINENT trial
by: Tsutomu Hirano, et al.
Published: (2023-07-01)

Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic
by: Hsin-hung Chen, et al.
Published: (2007-01-01)

Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy
by: Tsutomu Hirano, et al.
Published: (2023-12-01)

Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation
by: Wern Yew Ding, et al.
Published: (2022-09-01)

Relationship between subclasses low-density lipoprotein and carotid plaque
by: Pan Zhanhai, et al.
Published: (2022-03-01)

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
by: Juha Vakkilainen, et al.
Published: (2002-04-01)

Atherogenic dyslipidemia
by: C N Manjunath, et al.
Published: (2013-01-01)

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9
by: Holly E. Careskey, et al.
Published: (2008-02-01)

In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy
by: H.C. Geiss, et al.
Published: (2004-08-01)

Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia[S]
by: Elizabeth A. O'Hare, et al.
Published: (2014-11-01)

Comparison of Lipid Profile in Prediabetic and Non Prediabetic Adult Off-springs of Type 2 Diabetics Patients: A Cross-sectional Study
by: Sayali Eknathrao Raut, et al.
Published: (2022-06-01)

Dyslipidemia Among Patients of Rheumatoid Arthritis
by: Naseeb ur Rehman Shah , Mohammad Sajjad Khattak , Sami Ullah , Asim Muhammad
Published: (2021-12-01)

Screening and socioeconomic associations of dyslipidemia in young adults
by: Stephen E. Hudson, et al.
Published: (2020-01-01)

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism
by: John S. Millar, et al.
Published: (2008-03-01)

Effect of Morinda citrifolia (Noni) Fruit Juice on High Fat Diet Induced Dyslipidemia in Rats
by: Ahsan Shoeb, et al.
Published: (2016-04-01)

Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population
by: Francisco J. Tinahones, et al.
Published: (2005-03-01)

Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
by: Kuo-Hsuan Chang, et al.
Published: (2023-01-01)

How realistic are the LDL-C targets in new dyslipidemia guidelines - is it possible to reach the targets?
by: Barış Güngör
Published: (2020-03-01)

Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease
by: Ya-Ching Huang, et al.
Published: (2014-12-01)

Atherogenic Index of Plasma an Indicator for Predicting Cardiovascular Risk in Addition to Endothelial Dysfunction in Type 2 Diabetic Subjects
by: Siva Prasad Palem, et al.
Published: (2018-06-01)

The tangled web of dyslipidemia and cancer: Is there any association?
by: Sina Neshat, et al.
Published: (2022-01-01)

Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis
by: Zhang Bo, et al.
Published: (2007-05-01)

The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus
by: William L. Isley, et al.
Published: (2006-01-01)

Metabolic origins and clinical significance of LDL heterogeneity
by: Kaspar K. Berneis, et al.
Published: (2002-09-01)

A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia
by: Eyas Al Mousa, et al.
Published: (2023-06-01)

Role of Helicobacter pylori Infection on Diabetic and Lipid Profile in Pre-diabetic Patients
by: Akash Chaudhary, et al.
Published: (2021-03-01)

LDL and HDL transfer rates across peripheral microvascular endothelium agree with those predicted for passive ultrafiltration in humans
by: C. Charles Michel, et al.
Published: (2015-01-01)

The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis[S]
by: Yu-Xin Xu, et al.
Published: (2015-02-01)

Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy
by: Sabitha Palazhy, et al.
Published: (2017-01-01)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
by: Yukihito Higashi
Published: (2023-05-01)

Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): Results of the Dyslipidemia International Study (DYSIS)
by: Margus Viigimaa, et al.
Published: (2014-01-01)

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution
by: Susan J. Murdoch, et al.
Published: (2002-08-01)

Appraising risk of development of cardiovascular disease in patients with type 2 diabetes mellitus
by: Shadan Modaresahmadi, et al.
Published: (2018-01-01)

The inconspicuous health benefit of blood donation
by: Alhaji Bukar, et al.
Published: (2020-01-01)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
by: Alwhaibi M, et al.
Published: (2019-12-01)

Dyslipidemia in rheumatoid arthritis: the possible mechanisms
by: Jiahui Yan, et al.
Published: (2023-10-01)

Comparisons of the Relationships Between Multiple Lipid Indices and Diabetic Kidney Disease in Patients With Type 2 Diabetes: A Cross-Sectional Study
by: Chun-feng Lu, et al.
Published: (2022-07-01)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)

Association of Hypertensive Retinopathy with different serum lipid parameters in patients of Essential Hypertension: A Hospital Based Study
by: Bishwa Nath Adhikari, et al.
Published: (2018-12-01)

A comparison of anion-exchange and steric-exclusion HPLC assays of mouse plasma lipoproteins
by: Jonathan Neyer, et al.
Published: (2005-08-01)